United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,373 | 86,479 | 163,291 | 183,404 | 200,935 |
| Marketable Securities | 31,677 | 10,500 | N/A | 7,313 | 14,484 |
| Receivables | 4,224 | 3,129 | 3,153 | 2,601 | 1,534 |
| Inventories | 6,025 | 3,800 | 3,950 | 3,536 | 2,897 |
| Other current assets | 1,787 | 1,968 | 332 | 335 | 1,193 |
| TOTAL | $69,003 | $107,025 | $172,118 | $197,762 | $222,120 |
| Non-Current Assets | |||||
| PPE Net | 6,403 | 6,338 | 6,201 | 6,023 | 5,939 |
| Investments And Advances | 120,591 | 87,883 | 34,215 | 19,430 | 4,349 |
| Intangibles | 15,365 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 759 | 16,833 | 17,307 | 17,784 | 18,237 |
| TOTAL | $143,118 | $111,054 | $57,723 | $43,237 | $28,525 |
| Total Assets | $212,121 | $218,078 | $229,841 | $240,999 | $250,645 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 102 | 100 | 86 | 78 | 71 |
| Accounts payable and accrued liabilities | 6,667 | 5,173 | 6,096 | 6,957 | 5,952 |
| Accrued Expenses | 3,454 | 3,798 | 4,708 | 3,868 | 4,523 |
| Other current liabilities | 75 | 13 | 26 | 36 | N/A |
| TOTAL | $10,798 | $9,583 | $11,916 | $12,135 | $11,492 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,836 | 1,863 | 1,837 | 1,844 | 1,836 |
| Other Non-Current Liabilities | 3,088 | 3,060 | 2,493 | 2,229 | 2,579 |
| TOTAL | $4,924 | $4,923 | $4,330 | $4,073 | $4,415 |
| Total Liabilities | $15,722 | $14,505 | $16,246 | $16,207 | $15,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,450 | 40,450 | 40,507 | 40,507 | N/A |
| Common Shares | 208 | 208 | 208 | 207 | 207 |
| Retained earnings | -162,170 | -154,743 | -144,932 | -134,285 | -124,882 |
| Other shareholders' equity | 126 | 126 | 469 | -68 | -72 |
| TOTAL | $196,399 | $203,573 | $213,595 | $224,791 | $234,738 |
| Total Liabilities And Equity | $212,121 | $218,078 | $229,841 | $240,999 | $250,645 |